To further confirm that anti-RGMb mAb blockade of the BMP-2/4 and/or NEO1 binding site reduced GvHD, the recipient mice were sacrificed at 9 days after transplantation, and intestinal tissues were harvested. Here, RGMB is linked to graft versus host disease.